-
Puma Biotechnology’s NERLYNX Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer
FirstWordPharma
January 13, 2022
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the treatment...
-
Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization
prnewswire
January 05, 2022
Today, the National Comprehensive Cancer Network® (NCCN®) published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of COVID-19 in people with cancer.
-
Global Recommendations for Colon Cancer Translated into Multiple Languages as NCCN Expands Arabic Resources
prnasia
December 23, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of newly-translated recommendations for treating colon cancer in Arabic...
-
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
prnasia
December 07, 2021
The National Comprehensive Cancer Network (NCCN®)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used resource for enabling discussion and treatment of distress as part of routine care...
-
When and How to Screen for Colorectal Cancer? New NCCN Patient Guideline Explains Latest Timing and Approaches
prnasia
December 02, 2021
The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients®: Colorectal Cancer Screening.
-
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
prnasia
October 25, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition.
-
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year
prnasia
October 14, 2021
The National Comprehensive Cancer Network (NCCN®) today announced the publication of new NCCN Guidelines for Patients® Basal Cell Skin Cancer (also known as basal cell carcinoma, or BCC), the most common form of skin cancer.
-
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese
prnewswire
September 13, 2021
During Prostate Cancer Awareness Month the National Comprehensive Cancer Network is announcing up-to-date, translated guidelines featuring recent advances in care for one of the most-common types of cancer
-
New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer
prnasia
June 22, 2021
The National Comprehensive Cancer Network (NCCN®) announced the publication of new NCCN Guidelines for Patients® Anal Cancer, in addition to recently updated patient guidelines for colon and rectal cancers.
-
New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in Children
prnasia
February 18, 2021
The National Comprehensive Cancer Network® (NCCN®) published its first-ever treatment guidelines for children with a solid tumor cancer type in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for ...